PAX8 and thyroid cancer, nonmedullary, 2: Out of the 17 abnormal molecular results in FTC, 4 (23.5%) exhibited a PAX8/PPARγ alteration and 2 (11.8%) showed a PTEN alteration, markers that were both exclusive to FTC in our study.